BALCX
Price
$34.14
Change
+$0.30 (+0.89%)
Updated
May 2 closing price
Net Assets
234.89B
FOBPX
Price
$19.16
Change
+$0.13 (+0.68%)
Updated
May 2 closing price
Net Assets
78.24M
Ad is loading...

BALCX vs FOBPX

Header iconBALCX vs FOBPX Comparison
Open Charts BALCX vs FOBPXBanner chart's image
American Funds American Balanced C
Price$34.14
Change+$0.30 (+0.89%)
VolumeN/A
Net Assets234.89B
Tributary Balanced Instl Plus
Price$19.16
Change+$0.13 (+0.68%)
VolumeN/A
Net Assets78.24M
BALCX vs FOBPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BALCX vs. FOBPX commentary
May 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Buy and FOBPX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 235B vs. FOBPX (78.2M). FOBPX pays higher dividends than BALCX: FOBPX (1.56) vs BALCX (1.29). BALCX was incepted earlier than FOBPX: BALCX (24 years) vs FOBPX (14 years). BALCX (1.31) is less costly to investors than FOBPX (1.07). BALCX is a more actively managed with annual turnover of: 44.00 vs. FOBPX (19.00). BALCX has a lower initial minimum investment than FOBPX: BALCX (250) vs FOBPX (5000000). BALCX annual gain was more profitable for investors over the last year : 6.13 vs. FOBPX (3.98). BALCX return over 5 years is better than : 34.84 vs. FOBPX (22.51).
BALCXFOBPXBALCX / FOBPX
Total Expense Ratio1.310.77170%
Annual Report Gross Expense Ratio1.311.07122%
Fund Existence24 years14 years-
Gain YTD0.398-1.851-21%
Front LoadN/AN/A-
Min. Initial Investment25050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets235B78.2M300,512%
Annual Yield % from dividends1.291.5683%
Returns for 1 year6.133.98154%
Returns for 3 years16.9010.69158%
Returns for 5 years34.8422.51155%
Returns for 10 years45.4423.17196%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBIX109.683.09
+2.90%
Neurocrine Biosciences
IART16.850.41
+2.49%
Integra LifeSciences Holdings Corp
MITK8.240.14
+1.73%
Mitek Systems
SNGX1.92N/A
+0.21%
Soligenix Inc.
NKTR0.75-0.03
-3.60%
Nektar Therapeutics